Request a quote by adding to cart
Search assays by targets
Allplex™ 2019-nCoV Assay has an Emergency Use Authorization in the US. Novaplex™ is for Research Use Only. Not for Use in Diagnostic Procedures.
-
Targets
- Mycoplasma genitalium (MG)
- A2058C (mutation of 23S rRNA)
- A2058G (mutation of 23S rRNA)
- A2058T (mutation of 23S rRNA)
- A2059C (mutation of 23S rRNA)
- A2059G (mutation of 23S rRNA)
- A2059T (mutation of 23S rRNA)
-
Targets
- Mycoplasma genitalium (MG)
- G248A (mutation of parC)
- A247C (mutation of parC)
- G248T (mutation of parC)
- G259A (mutation of parC)
- G259C (mutation of parC)
- G259T (mutation of parC)
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
-
Targets
- Mycobacterium tuberculosis (MTB)
- Extensive drug resistance (13 mutations)
- Injectable drug-resistance (6 mutations)
- Fluoroquinolone-resistance (7 mutations)
-
Targets
- A2059G (mutation of 23S rRNA)
- C2611T (mutation of 23S rRNA)
- S91F (mutation of gyrase A)
- Neisseria gonorrhoeae (NG1)
- Neisseria gonorrhoeae (NG2)
-
Targets
- Plasmodium vivax (PV)
- Plasmodium ovale (PO)
- Plasmodium falciparum (PF)
- Plasmodium malariae (PM)
- Plasmodium knowlesi (PK)
-
Targets
- Borrelia mayonii
- Borrelia burgdoferi sensu stricto
- Babesia duncani
- Babesia microti
- Borrelia miyamotoi (BMi)
- Rickettsia spp. (Rcke)
- Anaplasma phagocytophilum (AP)
- Ehrlichia ewingii
- Ehrlichia chaffensis
-
Targets
- Dengue virus (DENV)
- Chikungunya virus (CHIKV)
- Zika virus (ZIKV)
- West Nile virus (WNV)